MVIS US Listed Biotech 25 Index

The modified market cap-weighted index tracks the performance of the largest and most liquid US-listed companies that generate at least 50% of their revenues from biotechnology. The pure-play index contains only companies which are engaged primarily in research and development as well as production, marketing and sales of drugs based on genetic analysis and diagnostic equipment. The MVIS US Listed Biotech 25 Index (MVBBH) has been licensed to underlie financial products with currently USD 367.5 million in assets under management.

Index Performance

Index performance of price, total return net and total return gross indices is displayed in realtime.

PeriodPriceTotal Return NetTotal Return Gross
Year-to-Date Performance24.40%24.97%25.17%
1-Year Performance17.04%17.63%17.84%
3-Year Performance29.60%31.70%32.48%
5-Year Performance16.43%19.20%20.27%
Since Inception (29 Sep 2000)224.08%234.86%353.14%

Index Records

Index highs and lows of price, total return net and total return gross indices are displayed in realtime.

PeriodPriceTotal Return NetTotal Return Gross
All Time High/Low3,367.70 / 312.69 3,407.55 / 312.71 4,611.19 / 1,000.00
52-Weeks High/Low3,298.58 / 2,421.18 3,407.55 / 2,490.21 4,611.19 / 3,364.26
Quarter High/Low3,298.58 / 2,681.94 3,407.55 / 2,768.67 4,611.19 / 3,745.68
Month High/Low3,298.58 / 3,059.40 3,407.55 / 3,158.35 4,611.19 / 4,272.86

Index Correlation and Volatility

Index correlation to selected index peers and index volatility are updated daily.

Index Correlation
MSCI ACWI Biotechnology0.9006
DJ US Biotechnology TSM0.9377
Index Volatility
22-day Volatility12.57
250-day Volatility20.01

Component Performance

Displayed are the best and worst index components over a selected period of time. Data is updated daily.

Best 5 Components1-YearYear-to-Date1-Day
ALEXION PHARMACEUTICALS INC-4.64%12.47%-1.53%
AMGEN INC22.93%23.88%0.07%
BIOGEN INC-8.62%-2.89%-1.67%
BIOMARIN PHARMACEUTICAL INC-14.70%-7.49%-0.83%
CHARLES RIVER LABORATORIES13.53%29.21%0.01%
GILEAD SCIENCES INC3.85%11.49%1.04%
ILLUMINA INC-2.53%6.88%-1.95%
INCYTE CORP44.71%49.28%-0.83%
REGENERON PHARMACEUTICALS-0.58%0.01%1.59%
SEATTLE GENETICS INC82.70%96.51%-2.32%
UNITED THERAPEUTICS CORP-15.76%-15.07%-0.58%
VERTEX PHARMACEUTICALS INC27.00%32.76%-0.12%
ALNYLAM PHARMACEUTICALS INC54.69%62.93%-2.50%
GRIFOLS SA-ADR22.25%25.32%-1.13%
ALLERGAN PLC27.14%42.39%0.55%
BLUEBIRD BIO INC-17.03%-12.33%1.49%
IONIS PHARMACEUTICALS INC14.35%14.11%-1.94%
NEUROCRINE BIOSCIENCES INC32.05%58.59%-0.35%
QIAGEN NV18.15%20.17%-0.67%
IQVIA HOLDINGS INC18.39%23.82%-1.56%
EXACT SCIENCES CORP22.51%34.98%-0.15%
SAREPTA THERAPEUTICS INC-18.84%-7.04%-4.45%
BEIGENE LTD-ADR31.51%28.28%-1.34%
GUARDANT HEALTH INC61.82%88.29%-3.49%
Worst 5 Components1-YearYear-to-Date1-Day
ALEXION PHARMACEUTICALS INC-4.64%12.47%-1.53%
AMGEN INC22.93%23.88%0.07%
BIOGEN INC-8.62%-2.89%-1.67%
BIOMARIN PHARMACEUTICAL INC-14.70%-7.49%-0.83%
CHARLES RIVER LABORATORIES13.53%29.21%0.01%
GILEAD SCIENCES INC3.85%11.49%1.04%
ILLUMINA INC-2.53%6.88%-1.95%
INCYTE CORP44.71%49.28%-0.83%
REGENERON PHARMACEUTICALS-0.58%0.01%1.59%
SEATTLE GENETICS INC82.70%96.51%-2.32%
UNITED THERAPEUTICS CORP-15.76%-15.07%-0.58%
VERTEX PHARMACEUTICALS INC27.00%32.76%-0.12%
ALNYLAM PHARMACEUTICALS INC54.69%62.93%-2.50%
GRIFOLS SA-ADR22.25%25.32%-1.13%
ALLERGAN PLC27.14%42.39%0.55%
BLUEBIRD BIO INC-17.03%-12.33%1.49%
IONIS PHARMACEUTICALS INC14.35%14.11%-1.94%
NEUROCRINE BIOSCIENCES INC32.05%58.59%-0.35%
QIAGEN NV18.15%20.17%-0.67%
IQVIA HOLDINGS INC18.39%23.82%-1.56%
EXACT SCIENCES CORP22.51%34.98%-0.15%
SAREPTA THERAPEUTICS INC-18.84%-7.04%-4.45%
BEIGENE LTD-ADR31.51%28.28%-1.34%
GUARDANT HEALTH INC61.82%88.29%-3.49%
Up